Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in VSports app下载. gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. V体育官网.

Review
. 2020 Apr 16;27(4):436-447.
doi: 10.1016/j.chembiol.2020.03.011. Epub 2020 Apr 9.

Breakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating Ferroptosis

Annadurai Anandhan  1 , Matthew Dodson  1 , Cody J Schmidlin  1 , Pengfei Liu  1 , Donna D Zhang  2
Affiliations
Review

Breakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating Ferroptosis

Annadurai Anandhan et al. Cell Chem Biol. .

Abstract

Ferroptosis is a non-apoptotic mode of regulated cell death that is iron and lipid peroxidation dependent. As new mechanistic insight into ferroptotic effectors and how they are regulated in different disease contexts is uncovered, our understanding of the physiological and pathological relevance of this mode of cell death continues to grow. Along these lines, a host of pharmacological modulators of this pathway have been identified, targeting proteins involved in iron homeostasis; the generation and reduction of lipid peroxides; or cystine import and glutathione metabolism. Also, of note, many components of the ferroptosis cascade are target genes of the transcription factor nuclear factor erythroid 2-related factor 2 (NRF2), indicating its critical role in mediating the ferroptotic response. In this review, we discuss the in vitro, in vivo, and clinical evidence of ferroptosis in disease, including a brief discussion of targeting upstream mediators of this cascade, including NRF2, to treat ferroptosis-driven diseases. VSports手机版.

Keywords: NRF2; cancer; cardiovascular disease; cell death; diabetes; ferritinophagy; ferroptosis; iron; lipid peroxidation; neurodegeneration. V体育安卓版.

PubMed Disclaimer

Figures (VSports注册入口)

Figure 1:
Figure 1:. NRF2 regulates genes involved in preventing ferroptosis.
Under homeostatic conditions, NRF2 is ubiquitylated and targeted for proteasomal degradation by a KEAP1-CUL3-RBX1 E3 ubiquitin ligase complex. Under conditions of oxidative/electrophilic stress, or as a result of mutations in KEAP1, CUL3, or NRF2 itself, NRF2 is no longer degraded, allowing for nuclear translocation and activation of antioxidant response element (ARE)-containing genes. NRF2 transcriptional targets are involved in mediating iron/metal metabolism, the catabolism/detoxification of reactive intermediates, and glutathione synthesis and metabolism, all of which play a key role in preventing initiation of ferroptosis.
Figure 2:
Figure 2:. Iron metabolism and ferritinophagy and their regulation by NRF2.
Ferric iron (Fe3+) in the blood is bound and transported by transferrin (Ferretti et al.). Fe3+-TR is bound by transferrin receptor 1 (TFRC) and endocytosed. In the endosome, the acidic pH promotes dissociation of TFRC and Fe3+, which is then reduced to Fe2+ by the metalloreductase STEAP3. Fe2+ is then transported to the cytosol by divalent metal transporter 1 (DMT1), contributing to the labile iron pool (LIP). Fe2+ can be exported out of cells by ferroportin (FPN1), incorporated into iron-containing proteins, or bound and stored by ferritin as Fe3+. Ferritinophagy is the autophagy-dependent degradation of ferritin via nuclear receptor coactivator 4 (NCOA4). Following ferritin degradation, newly freed Fe3+ is reduced to Fe2+ by STEAP3 and exported from the lysosome into the cytosol by DMT1 to again become part of the LIP, where it can subsequently react with ROS via the Fenton reaction. Importantly, a number of key iron metabolism, storage, and transport, as well as key autophagy/ferritinophagy initiation genes are transcriptionally regulated by NRF2.
Figure 3:
Figure 3:. Ferroptosis and its role in disease.
Ferroptosis has been shown to play a role in neurodegeneration, cardiovascular disease, diabetes, and cancer, among others. In cancer, the therapeutic goal is to activate ferroptosis to kill tumor cells that are resistant to other modes of cell death. In neurodegeneration, type II diabetes, and cardiovascular disease, the therapeutic goal is to prevent ferroptosis-induced cell loss to slow onset or mitigate disease progression. Inducers and inhibitors of ferroptosis that have been shown to affect experimental models of each disease in vitro and in vivo, or patients in clinic, are also included.
Figure 4:
Figure 4:. Modulation of NRF2 to target ferroptosis-driven diseases.
NRF2 regulates the expression of enzymes responsible for glutathione synthesis (GLC and GSS), as well as preventing lipid peroxidation and reducing oxidized CoQ10, a key membrane antioxidant (GPX4 and FSP1). Lipid peroxides are key initiators of ferroptosis, which has been shown to be involved in numerous diseases, including cancer, type II diabetes, cardiovascular disease, and neurodegeneration.
See this image and copyright information in PMC

References

    1. Adibhatla RM, and Hatcher JF (2010). Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 12, 125–169. - "V体育平台登录" PubMed
    1. Agrawal S, Berggren KL, Marks E, and Fox JH (2017). Impact of high iron intake on cognition and neurodegeneration in humans and in animal models: a systematic review. Nutr Rev 75, 456–470. - PMC (V体育官网入口) - PubMed
    1. Alvarez SW, Sviderskiy VO, Terzi EM, Papagiannakopoulos T, Moreira AL, Adams S, Sabatini DM, Birsoy K, and Possemato R (2017). NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature 551, 639–643. - PMC - PubMed
    1. Angeli JPF, Shah R, Pratt DA, and Conrad M (2017). Ferroptosis Inhibition: Mechanisms and Opportunities. Trends Pharmacol Sci 38, 489–498. - PubMed (VSports app下载)
    1. Aubrey BJ, Kelly GL, Janic A, Herold MJ, and Strasser A (2018). How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ 25, 104–113. - PMC - PubMed

"VSports" Publication types